The Stability, and Efficacy Against Penicillin-Resistant Enterococcus faecium, of the Plectasin Peptide Efficiently Produced by Escherichia coli
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Plectasin, the first defensin extracted from a fungus (the saprophytic ascomycete Pseudoplectania nigrella), is attractive as a prospective antimicrobial agent. The purpose of this study was to establish a bacterium-based production system and evaluate the antimicrobial activity of the resulting plectasin. A gene encoding plectasin, with the codon preference of Escherichia coli, was optimized based on its amino acid sequence, synthesized using genesplicing with overlap extension PCR, and inserted into the expression vector pGEX-4T-1. The fusion protein was expressed in the soluble fraction of E. coli and purified using glutathione Stransferase affinity chromatography. Plectasin was cleaved from the fusion protein with thrombin and purified by ultrafiltration. The purified plectasin showed strong, concentrationdependent antimicrobial activity against gram-positive bacteria, including antibiotic-resistant bacteria, especially penicillin-resistant Enterococcus faecium. This antimicrobial activity was equal to chemically synthesized plectasin and was maintained over a wide range of pH and temperatures. This soluble recombinant expression system in E. coli is effective for producing plectasin at a relatively lower cost, and higher purity and efficiency than prior systems, and might provide a foundation for developing a large-scale production system. Overall, plectasin shows potential as a novel, high-performance, and safe antibiotic for the treatment of refractory diseases caused by drug-resistant bacterial strains.
Abstract
Plectasin, the first defensin extracted from a fungus (the saprophytic ascomycete Pseudoplectania nigrella), is attractive as a prospective antimicrobial agent. The purpose of this study was to establish a bacterium-based production system and evaluate the antimicrobial activity of the resulting plectasin. A gene encoding plectasin, with the codon preference of Escherichia coli, was optimized based on its amino acid sequence, synthesized using genesplicing with overlap extension PCR, and inserted into the expression vector pGEX-4T-1. The fusion protein was expressed in the soluble fraction of E. coli and purified using glutathione Stransferase affinity chromatography. Plectasin was cleaved from the fusion protein with thrombin and purified by ultrafiltration. The purified plectasin showed strong, concentrationdependent antimicrobial activity against gram-positive bacteria, including antibiotic-resistant bacteria, especially penicillin-resistant Enterococcus faecium. This antimicrobial activity was equal to chemically synthesized plectasin and was maintained over a wide range of pH and temperatures. This soluble recombinant expression system in E. coli is effective for producing plectasin at a relatively lower cost, and higher purity and efficiency than prior systems, and might provide a foundation for developing a large-scale production system. Overall, plectasin shows potential as a novel, high-performance, and safe antibiotic for the treatment of refractory diseases caused by drug-resistant bacterial strains.
참고문헌 (18)
- Brinch KS, "Influence of antidrug antibodies on plectasin efficacy and pharmacokinetics", Antimicrob. Agents Chemother, 53, pp.4794~4800 (2009)
- Brinch KS, "Plectasin shows intracellular activity against Staphylococcus aureus in human THP-1 monocytes and in a mouse peritonitis model", Antimicrob. Agents Chemother, 53, pp.4801~4808 (2009)
- Chen X, "Molecular chaperones (TrxA, SUMO, Intein, and GST)mediating expression, purification, and antimicrobial activity assays of plectasin in Escherichia coli", Biotechnol. Appl. Biochem, pp.1303~ (2014)[DOI]
- Huang L, "Soluble fusion expression and characterization of bioactive human beta-defensin 26and 27", Appl. Microbiol. Biotechnol, 84, pp.301~308 (2009)
- Ingham AB, "Recombinant production of antimicrobial peptides in heterologous microbial systems", Biotechnol. Appl. Biochem, 47, pp.1~9 (2007)
- Jing XL, "High-level expression of the antimicrobial peptide plectasin in Escherichia coli", Curr. Microbiol, 61, pp.197~202 (2010)
- Kane JF, "Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli", Curr. Opin. Biotechnol, 6, pp.494~500 (1995)
- Kim JM, "High-level expression of an antimicrobial peptide histonin as a natural form by multimerization and furin-mediated cleavage", Appl. Microbiol. Biotechnol, 78, pp.123~130 (2008)
- Mao R, "Design, expression, and characterization of a novel targeted plectasin against methicillin-resistant Staphylococcus aureus", Appl. Microbiol. Biotechnol, 97, pp.3991~4002 (2013)
- Mygind PH, "Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus", Nature, 437, pp.975~980 (2005)
- Padovan L, "Techniques for plant defensin production", Curr. Protein Pept. Sci, 11, pp.231~235 (2010)
- Rossolini GM, "Update on the antibiotic resistance crisis", Curr. Opin. Pharmacol, 18, pp.56~60 (2014)
- Rothan HA, "Antiviral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus:high yield production of the biologically active recombinant plectasin peptide", Omics, 17, pp.560~567 (2013)
- Schneider T, "Plectasin, a fungal defensin, targets the bacterial cell wall precursor lipid II", Science, 328, pp.1168~1172 (2010)
- Sharrocks AD, "A T7 expression vector for producing N- and C-terminal fusion proteins with glutathione Stransferase", Gene, 138, pp.105~108 (1994)
- Tian ZG, "Expression of antimicrobial peptide LH multimers in Escherichia coli C43(DE3)", Appl. Microbiol. Biotechnol, 83, pp.143~149 (2009)
- Zhang J, "Expression of plectasin in Pichia pastoris and its characterization as a new antimicrobial peptide against Staphyloccocus and Streptococcus", Protein Expr. Purif, 78, pp.189~196 (2011)
- Zorko M, "Production of recombinant antimicrobial peptides in bacteria", Methods Mol. Biol, 618, pp.61~76 (2010)